ELIC — Elicera Therapeutics AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK45.27m
- SEK4.56m
- SEK11.23m
Annual cashflow statement for Elicera Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | — | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.194 | -2.83 | -13.1 | -19.4 | -17.1 |
| Depreciation | |||||
| Amortisation | |||||
| Changes in Working Capital | -0.045 | 1.91 | -1.19 | 10.8 | 2.16 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.239 | -0.905 | -14.3 | -8.57 | -14.9 |
| Capital Expenditures | — | -0.059 | — | — | -0.001 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.217 | 0.05 | -0.001 | 0 | 0.484 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | 0.217 | -0.009 | -0.001 | 0 | 0.483 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0 | 12.4 | 55.1 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.022 | 11.5 | 40.8 | -8.57 | -14.4 |